January 30, 2021 5:36 pm Published by admin Immunicum AB (publ) Receives FDA Orphan Drug Designation for Ilixadencel as a Treatment of Soft Tissue Sarcoma (STS) Immunicum AB (publ; IMMU.ST) announced today that it has received Orphan Drug Designation (ODD) from the U.S. Food and Drug Administration (FDA) for the Company’s lead candidate, ilixadencel, a cell-based, off-the-shelf immune primer, for the treatment of [...]
January 30, 2021 5:31 pm Published by admin Testing the Combination of Belinostat and SGI-110 (Guadecitabine) for the Treatment of Unresectable and Metastatic Conventional Chondrosarcoma This phase II trial studies the effect of belinostat and SGI-110 (guadecitabine) combination therapy in treating patients with conventional chondrosarcoma that cannot be removed by surgery (unresectable) and has spread to other places in the body (metastatic). Belinostat [...]
January 27, 2021 8:54 pm Published by admin We are 11 days from Chondrosarcoma Awareness Day. If you have not already done this, we are counting on you to do the following: 1. Get the Word Out. Join us in our efforts to educate the public about Chondrosarcoma, a rare bone and soft tissue cancer effecting an estimated 4500 people in the US [...]
January 24, 2021 7:37 pm Published by admin The Chondrosarcoma Awareness Day is getting the attention from many media outlets across the globe. We are doing our best to raise awareness and support for Chondrosarcoma research and clinical trials. Please check out the links below: Chondrosarcoma CS Foundation, Inc. Initiates Worldwide Campaign to Proclaim February 6, 2021 As Chondrosarcoma Awareness Day | Boston [...]
January 21, 2021 7:27 pm Published by admin The Bowie, MD-based Chondrosarcoma CS Foundation, Inc. is launching an international public campaign to raise awareness and support for Chondrosarcoma research and clinical trials. They are proclaiming February 6, 2021, as Chondrosarcoma Awareness Day, and are encouraging supporters to join them in raising awareness about this rare cancer. Chondrosarcoma is a rare bone and soft [...]
January 18, 2021 2:03 am Published by admin Inhibrx Granted Fast Track Designation for INBRX-109 for the Treatment of Unresectable or Metastatic Conventional Chondrosarcoma Patients Registration-enabling study expected to begin dosing in the second or third quarter of this year SAN DIEGO, Jan. 13, 2021 /PRNewswire/ — Inhibrx, Inc. (Inhibrx), a clinical-stage biotechnology company with a broad pipeline of biotherapeutics in development, announced [...]
January 18, 2021 2:01 am Published by admin Inhibrx Granted Fast Track Designation for INBRX-109 for the Treatment of Unresectable or Metastatic Conventional Chondrosarcoma Patients Registration-enabling study expected to begin dosing in the second or third quarter of this year Inhibrx, Inc. logo (PRNewsfoto/Inhibrx, Inc.) SAN DIEGO, Jan. 13, 2021 /PRNewswire/ — Inhibrx, Inc. (Inhibrx), a clinical-stage biotechnology company with a broad pipeline [...]
January 16, 2021 3:53 am Published by admin Momentum is growing for our international public awareness campaign to support Chondrosarcoma Research and Clinical Trials. As you know Chondrosarcoma Awareness Day is dedicated to honor the legacy of Shayna Elise Kramer who passed away from this rare cancer in November, 2019. This February 6, would have been her 30th birthday. It was Shayna’s wish [...]
January 15, 2021 5:55 pm Published by admin In the effort to get the word out the Chondrosarcoma Foundation has sent a press release out to many media outlets to initiate an international public awareness campaign to support Chondrosarcoma Research and Clinical Trials. We declare February 6, Chondrosarcoma Awareness Day. We invite you to read the following article from the Daily Times Leader: [...]
January 9, 2021 7:30 pm Published by admin Chondrosarcoma is a rare bone and soft tissue cancer. Estimates are it effects 4,500 worldwide and approximately 650 in the United States each year. No one knows the origin of Chondrosarcoma or whether a hereditary pre-disposition exists. There is no known cure for Chondrosarcoma. The only treatment for Chondrosarcoma is the surgical removal of the [...]
